Results 61 to 70 of about 157,002 (240)
[News Clip: Blind Animal Dealer]
Video footage from the WBAP-TV station in Fort Worth, Texas to accompany a news story about Dale Logston, a blind animal dealer who sells dangerous wild ...
WBAP-TV (Television station : Fort Worth, Tex.)
core
Abstract Existing monitoring frameworks for sustainability certification schemes and labels (CSLs) have largely prioritised environmental aspects, while the social and economic pillars of sustainability remain comparatively underdeveloped. Also, dedicated circularity requirements tailored to biobased systems are still largely lacking, despite being ...
Iris Vural Gursel +5 more
wiley +1 more source
Other title: Dealer on-line registration system
Rev. 10/99.; Cover title.; "Dealer On-Line Procedure Manual"--Introduction.; Accompanied by 1 sheet of automobile registration cards and 1 application for duplicate certificate of title, with cover ...
Connecticut. Department of Motor Vehicles. Dealers and Repairers Division
core +2 more sources
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley +1 more source
Transaction Costs in Dealer Markets: Evidence From The London Stock Exchange [PDF]
This paper describes regularities in the intraday spreads and prices quoted by dealers on the London Stock Exchange. It develops a measure of spread-related transaction costs, one that recognizes dealers' willingness to price trades within their quoted ...
Peter C. Reiss, Ingrid M. Werner
core
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola +5 more
wiley +1 more source
Capacity building in medicines development and regulation in Africa—Overview on recent progress
Aims Despite advances in health research and digital innovation, many African countries continue to face substantial resource constraints, fragmented capacity‐building efforts and a shortage of skilled professionals in medicines development and regulatory science.
Tirhani Maluleke +7 more
wiley +1 more source
Tujuan dari penelitian ini adalah untuk mengetahui perhitungan pajak penghasilan badan yang dilakukan oleh Perusahaan Authorized Dealer dan untuk membandingkan perhitungan PPh Badan atas laporan keuangan komersial dengan Undang-Undang Perpajakan.
Ningrum, Tita Juwita
core

